|
Type of infection
|
N
|
Percentage (95 % CI)
|
|---|
|
HR HPV:
|
|
HPV 16
|
25
|
33.8 % (22.8–44.8)
|
|
HPV 18
|
13
|
17.6 % (8.7–26.4)
|
|
HPV 31
|
11
|
14.9 % (6.6–23.2)
|
|
HPV 33
|
12
|
16.2 % (7.6–24.8)
|
|
HPV 35
|
13
|
17.6 % (8.7–26.4)
|
|
HPV 45
|
3
|
4.1 % (0.5–8.7)
|
|
HPV 39
|
8
|
10.8 % (3.6–18.1)
|
|
HPV 51
|
11
|
14.9 % (6.6–23.2)
|
|
HPV 52
|
15
|
20.3 % (10.9–29.6)
|
|
HPV 53
|
18
|
24.3 % (14.3–34.4)
|
|
HPV 56
|
15
|
20.3 % (10.9–29.6)
|
|
HPV 58
|
13
|
17.6 % (8.7–26.4)
|
|
HPV 66
|
11
|
14.9 % (6.6–23.2)
|
|
HPV 68
|
4
|
5.4 % (0.1–10.7)
|
|
Multiple HR HPV
|
48
|
64.9 % (53.7–76.0)
|
|
Women on HAART
|
60
|
82.0 (80.0–90.2)
|
|
LR HPV:
|
|
HPV 6
|
4
|
5.4 % (4.4–6.4)
|
|
HPV 67
|
0
|
0
|
|
No HPV infection:
|
6
|
8.1 % (3.0–16.8)
|
|
STIs:
|
|
BV
|
46
|
62.2 % (50.9–73.5)
|
|
Genital ulcer
|
12
|
16.2 % (7.6–24.8)
|
|
Genital warts
|
8
|
10.8 % (3.6–18.1)
|
|
Trichomonas vaginalis
|
1
|
1.4 % (0.1–4.0)
|
|
Cervicitis
|
11
|
14.9 % (6.6–23.2)
|
|
STI prevalence
|
51
|
68.9 % (58.1–79.7)
|
|
More than one STI
|
8
|
10.7 % (3.5–17.8)
|
